NHIF Announces Finalists for 2025 Outstanding Abstract Achievement Award

Alexandria, VA (February 12, 2025)—The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2025. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient. The winner of the Outstanding Abstract Achievement Award will be announced at NHIA’s Annual Conference in Washington, D.C..

The finalists were selected based on how well their project examines innovative approaches to clinical practice, identifies an opportunity or best practice, or demonstrates quality improvement within the home and alternate site infusion industry.

Implementation of a Pharmacist Intervention Tool to Optimize Subcutaneous Immune Globulin Administration for Home Infusion Patients
Katie Laskin, PharmD | Yale New Haven Health Home Infusion

Utilization and Tolerability of Crizanlizumab in the Home and Alternate Infusion Settings
Kascha Brown, PharmD, MS | Option Care Health

Social Determinants of Health Impact on Participant Perception with Intravenous Immunoglobulin Therapy
Leslie Myers, PharmD, IgCP | CSI Pharmacy

Utilization of Alternative Dosing Strategies for Infliximab and Infliximab Biosimilars in the Home Infusion Setting
Natalie D. Garcia, PharmD | Option Care Health

Home Parenteral Nutrition Diagnosis and Payer Trends: 2020-2023
Amy Braglia-Tarpey, MS, RD, CNSC | Amerita

Don’t miss the finalists’ presentations in a live webinar on March 12 at 12:00pm ET and the award presentation at the General Session on Tuesday, April 1.